Navigation Links
Gladstone scientist Warner C. Greene receives Washington University School of Medicine Alumni Award
Date:4/25/2012

SAN FRANCISCO, CAApril 25, 2012Warner C. Greene, MD, PhDwho directs virology and immunology research at the Gladstone Instituteshas won the 2012 Alumni Achievement Award from the Washington University School of Medicine in St. Louis (WUSTL).

This prestigious award acknowledges outstanding personal achievement and professional accomplishments, with a particular dedication to the Washington University Medical Center. Dr. Greene trained in the Medical Scientist Training Program at WUSTL, considered to be one of the finest physician-scientist training programs in the United States.

"It is an honor and a pleasure to receive this award," said Dr. Greene, who is also a senior investigator at Gladstone and a professor of medicine at the University of California, San Francisco (UCSF), with which Gladstone is affiliated. "It is indeed very gratifying to be recognized by my alma mater."

Other recipients of this year's Alumni Achievement Award include Keith Bridwell, MD; Gary Rachelefsky, MD and Pejman Salimpour, MD.

Under Dr. Greene's direction, virology and immunology research at Gladstone takes a multidisciplinary approach to fighting HIV/AIDSwhich remains a global scourge, with more than 30 million people worldwide living with HIV. He studies the molecular mechanisms that underlie HIV infection. Recently, Dr. Greene's lab identified human protein fragments in semen that enhance the ability of HIV to infect new cellsa discovery that one day could help stem the global spread of this deadly pathogen.

Earlier this month, Dr. Greene was also honored with the 2012 Distinguished Research Career Award from the Ohio State University Center for Retrovirus Research. This award pays tribute to the career of a scientist working in the field of retrovirology. Dr. Greene was recognized for his substantial body of work on the molecular biology, immunology and pathogenesis of HIV-1 and HTLV-1.

"We are delighted that Dr. Greene is being acknowledged for his work to overcome one of the world's most devastating diseases," said R. Sanders Williams, MD, president of Gladstone. "These honors are highly deserved and speak both to his high accomplishments and his dedication to patients."

A widely recognized expert in virology and immunology, Dr. Greene is a member of the Institute of Medicine of the National Academies and a fellow of the American Academy for the Advancement of Science. He is also the president of the Accordia Global Health Foundation, whose mission is to build alliances to fight infectious disease in Africa.

Dr. Greene also serves as co-director of the UCSF-GIVI Center for AIDS Research and is a member of the executive committees of the AIDS Research Institute and the Biomedical Sciences graduate program at UCSF. He is the author of more than 330 scientific papers and has been recognized as one of the 100 Most Cited Scientists in the world.

Before joining Gladstone in 1991 as the Founding Director of the Gladstone Institute of Virology and Immunology, Dr. Greene served as a Senior Investigator at the National Cancer Institute and a Professor of Medicine and Howard Hughes Investigator at Duke University Medical Center.

Dr. Greene earned a bachelor's degree at Stanford University and an MD/ PhD at the Washington University School of Medicine. He completed his internship and residency training in Medicine at the Massachusetts General Hospital at Harvard.


'/>"/>
Contact: Diane Schrick
diane.schrick@gladstone.ucsf.edu
415-734-2538
Gladstone Institutes
Source:Eurekalert

Related biology news :

1. Gladstone scientist Deepak Srivastava named fellow of the AAAS
2. Gladstone scientist receives American Heart Associations Katz prize for cardiovascular research
3. Gladstone founder receives American Heart Association Distinguished Scientist Award
4. Gladstone scientists identify protein form linked to Huntingtons disease
5. Gladstone scientist finds new target for treating symptoms of Parkinsons disease
6. Gladstone scientists offer new insight into the regulation of stem cells and cancer cells
7. Gladstone to receive $5.6 million in federal funds to seek a cure for AIDS
8. Gladstone scientists identify genes involved in embryonic heart development
9. Gladstone scientists uncover mechanism for the major genetic risk factor of Alzheimers disease
10. Gladstone scientists link hepatitis C virus infection to fat enzyme in liver cells
11. Gladstones Shinya Yamanaka wins Kyoto prize
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/2/2017)...   TapImmune, Inc. (NASDAQ: ... the development of innovative peptide and gene-based immunotherapeutics ... metastatic disease, announced today it has successfully completed ... second clinical lot of TPIV 200, the company,s ... manufactured vaccine product will be used to supply ...
(Date:2/1/2017)... IDTechEx Research, a leading provider of independent market research, business ... new report, Sensors for Robotics: Technologies, Markets and Forecasts 2017-2027 ... ... Revenues of ... for Robotics: Technologies, Markets and Forecasts 2017-2027: Machine vision, force sensing ...
(Date:1/26/2017)... Jan. 26, 2017  Crossmatch, a leading provider of ... solution aimed at combatting fraud, waste and abuse in ... at the Action on Disaster Relief conference in ... for UN agencies and foreign assistance organizations throughout ... and abuse are a largely unacknowledged problem in the ...
Breaking Biology News(10 mins):
(Date:2/28/2017)... ... , ... Over 8,000 recognized rare diseases afflict an estimated 350 million people ... March 7, DrugDev will gather international experts to share challenges and provide insight and ... Overcoming the Challenges of Rare Disease Clinical Trials, Date: March 7, 2017, Time: 10:00-11:00 ...
(Date:2/28/2017)... , ... February 28, 2017 , ... ... discovery of antibody therapeutics from millions-diverse immune repertoires, today announced a strategic partnership ... mouse strains genetically engineered to express human antibodies. The partnership will use GigaGen ...
(Date:2/28/2017)... PHILADELPHIA , Feb. 28, 2017 ... company focusing on debilitating diseases including rare genetic diseases ... the company joins with the National Organization for Rare ... support around the world in commemorating Rare Disease Day, ... and needs of the millions of patients and families ...
(Date:2/28/2017)... VANCOUVER , Feb. 28, 2017 /PRNewswire/ - RepliCel ... "Company"), a clinical stage regenerative medicine company developing unique ... and sun-damaged skin, and chronic tendon degeneration, today announced ... both of whom have committed to work with RepliCel ... manufactured and tested. ...
Breaking Biology Technology: